Who Paid My Doc Search
Menu
Product Program year 2025 Source: CMS Open Payments

Evis Exera III Colonovideoscope

Device Gastroenterology

PDI 04953170416118

Open in the dashboard

General payments

$1,406,910

1,529 payments

Research payments

$0

0 payments

Through program year 2025, $1,406,910 in general payments and $0 in research payments were reported against Evis Exera III Colonovideoscope (Gastroenterology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $812,866 798
2024 General $594,044 731

Breakdown

Who paid General payments · program years 2024–2025
  1. Olympus America Inc. $1,164,046 814 payments
  2. Olympus Corporation of the Americas $113,645 376 payments
  3. Olympus Corporation $107,800 279 payments
  4. Olympus Medical Systems Corporation $12,386 26 payments
  5. Olympus Latin America, Inc. $9,033 34 payments
Top recipients General payments · program year 2025
  1. Park Nicollet Methodist Hospital Teaching hospital · MN $167,567 21% · 1 payment
  2. University Medical Center Of El Paso Teaching hospital · TX $131,420 16% · 2 payments
  3. Regions Hospital Teaching hospital · MN $109,629 13% · 1 payment
  4. Nikhil Kumta Gastroenterology · New York, NY $35,733 4% · 39 payments
  5. The Brooklyn Hospital Center Teaching hospital · NY $23,298 3% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $180,178 59% · 179 practitioners
  2. Surgery $51,053 17% · 18 practitioners
  3. Internal Medicine $23,586 8% · 20 practitioners
  4. Colon & Rectal Surgery $19,815 7% · 27 practitioners
  5. Surgical Oncology Surgery $18,669 6% · 1 practitioner

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Minnesota $281,120 35% · 12 recipients
  2. Texas $137,254 17% · 55 recipients
  3. New York $72,112 9% · 25 recipients
  4. Florida $68,946 8% · 19 recipients
  5. Massachusetts $44,841 6% · 15 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Records

1,529 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record